-
1
-
-
0018931869
-
Dose: a critical factor in cancer chemotherapy
-
E. Frei G.P. Canellos Dose: a critical factor in cancer chemotherapy Am J M 69 1980 585 594
-
(1980)
Am J M
, vol.69
, pp. 585-594
-
-
Frei, E.1
Canellos, G.P.2
-
2
-
-
0031895477
-
In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols
-
K.H. Link G. Leder J. Pillasch U. Butzer L. Staib M. Kornmann In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols Semin Surg Oncol 14 1998 189 201
-
(1998)
Semin Surg Oncol
, vol.14
, pp. 189-201
-
-
Link, K.H.1
Leder, G.2
Pillasch, J.3
Butzer, U.4
Staib, L.5
Kornmann, M.6
-
3
-
-
0030823878
-
The advancement of high-dose chemotherapy and dose intensification schedules
-
R.C. Leonard The advancement of high-dose chemotherapy and dose intensification schedules Ann Oncol 8 Suppl 3 1997 3
-
(1997)
Ann Oncol
, vol.8 Suppl 3
, pp. 3
-
-
Leonard, R.C.1
-
4
-
-
0029796336
-
Chronopharmacologie et chronothérapie des cancers
-
F. Levi Chronopharmacologie et chronothérapie des cancers Pathol Biol 44 1996 631 644
-
(1996)
Pathol Biol
, vol.44
, pp. 631-644
-
-
Levi, F.1
-
5
-
-
0022982316
-
Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastases colon carcinoma
-
R.S. Leff J.M. Thompson D.B. Johnson K.R. Mosley M.B. Daly W.A.III Knight Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastases colon carcinoma J Clin Oncol 4 1989 1586 1591
-
(1989)
J Clin Oncol
, vol.4
, pp. 1586-1591
-
-
Leff, R.S.1
Thompson, J.M.2
Johnson, D.B.3
Mosley, K.R.4
Daly, M.B.5
Knight, W.A.III6
-
6
-
-
0009885824
-
Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas
-
A.M.M. Eggermont H. Schraffordt Koops J.M. Klausner B.B.R. Kroon P.M. Schlag D. Liénard Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas Ann Surg 224 1996 756 765
-
(1996)
Ann Surg
, vol.224
, pp. 756-765
-
-
Eggermont, A.M.M.1
Schraffordt Koops, H.2
Klausner, J.M.3
Kroon, B.B.R.4
Schlag, P.M.5
Liénard, D.6
-
7
-
-
0023724861
-
Bases rationnelles et résultats de la chimiothérapie intra-artérielle hépatique
-
P. Rougier P. Lasser D. Elias Bases rationnelles et résultats de la chimiothérapie intra-artérielle hépatique Ann Chir 42 1988 639 646
-
(1988)
Ann Chir
, vol.42
, pp. 639-646
-
-
Rougier, P.1
Lasser, P.2
Elias, D.3
-
8
-
-
0031217269
-
Locoregional therapy with hypoxic liver perfusion in malignant neoplasms of the gallbladder. Premiliminary experience
-
R. Roversi S. Ricci G. Rossi M. Roversi G. Cavallo Locoregional therapy with hypoxic liver perfusion in malignant neoplasms of the gallbladder. Premiliminary experience Radiol Med (Torino) 94 1997 220 225
-
(1997)
Radiol Med (Torino)
, vol.94
, pp. 220-225
-
-
Roversi, R.1
Ricci, S.2
Rossi, G.3
Roversi, M.4
Cavallo, G.5
-
9
-
-
8944240380
-
Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases
-
Y. Ku M. Tominaga T. Iwasaki T. Kitagawa I. Maeda M. Shiotani Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases Surg Today 26 1996 305 313
-
(1996)
Surg Today
, vol.26
, pp. 305-313
-
-
Ku, Y.1
Tominaga, M.2
Iwasaki, T.3
Kitagawa, T.4
Maeda, I.5
Shiotani, M.6
-
10
-
-
0002900189
-
Isolated liver perfusion: 5 years experience
-
K.R. Aigner Isolated liver perfusion: 5 years experience Reg Cancer Treat 1 1988 11 20
-
(1988)
Reg Cancer Treat
, vol.1
, pp. 11-20
-
-
Aigner, K.R.1
-
11
-
-
0345596439
-
Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
-
H.R. Alexander D.L. Bartlett S.K. Libutti D.L. Fraker T. Moser S.A. Rosenberg Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver J Clin Oncol 16 1998 1479 1489
-
(1998)
J Clin Oncol
, vol.16
, pp. 1479-1489
-
-
Alexander, H.R.1
Bartlett, D.L.2
Libutti, S.K.3
Fraker, D.L.4
Moser, T.5
Rosenberg, S.A.6
-
12
-
-
0031839319
-
First experience and technical aspects of isolated liver perfusion for extensive liver metastasis
-
K.J. Oldhafer H. Lang M. Frerker L. Moreno A. Chavan P. Flemming First experience and technical aspects of isolated liver perfusion for extensive liver metastasis Surgery 123 1998 622 631
-
(1998)
Surgery
, vol.123
, pp. 622-631
-
-
Oldhafer, K.J.1
Lang, H.2
Frerker, M.3
Moreno, L.4
Chavan, A.5
Flemming, P.6
-
13
-
-
0031616199
-
Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF alpha and melphalan: Swedish experience. Recent results
-
L. Hafström P. Naredi Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF alpha and melphalan: Swedish experience. Recent results Cancer Res 147 1998 120 126
-
(1998)
Cancer Res
, vol.147
, pp. 120-126
-
-
Hafström, L.1
Naredi, P.2
-
14
-
-
0032471947
-
Isolated hypoxic perfusion with tumor necrosis factor-alpha, melphalan and mitomycine C using balloncatheter techniques: a pharmacokinetic study in pigs
-
M.G.A. Van Ijken E.A. De Bruijn G.D. De Boeck T.L.M. Ten Hagen J.R.M. Van Der Sijp A.M.M. Eggermont Isolated hypoxic perfusion with tumor necrosis factor-alpha, melphalan and mitomycine C using balloncatheter techniques: a pharmacokinetic study in pigs Ann Surg 228 1998 763 770
-
(1998)
Ann Surg
, vol.228
, pp. 763-770
-
-
Van Ijken, M.G.A.1
De Bruijn, E.A.2
De Boeck, G.D.3
Ten Hagen, T.L.M.4
Van Der Sijp, J.R.M.5
Eggermont, A.M.M.6
-
15
-
-
0023835483
-
In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-fluorouracil concentrations in tumor tissue
-
L.M. De Brauw C.J.H. Van De Velde U.R. Tjaden E.A. De Bruijn A.V.R.J. Bell J. Hermans In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-fluorouracil concentrations in tumor tissue J Surg Res 44 1988 137 145
-
(1988)
J Surg Res
, vol.44
, pp. 137-145
-
-
De Brauw, L.M.1
Van De Velde, C.J.H.2
Tjaden, U.R.3
De Bruijn, E.A.4
Bell, A.V.R.J.5
Hermans, J.6
-
16
-
-
0030797412
-
Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimb
-
Z.Y. Wu B.M. Smithers M.S. Roberts Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimb Melanoma Res 7 1997 252 264
-
(1997)
Melanoma Res
, vol.7
, pp. 252-264
-
-
Wu, Z.Y.1
Smithers, B.M.2
Roberts, M.S.3
-
18
-
-
0021238925
-
Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma
-
L. Hafström A. Hugander P.E. Jönsson H. Westling H. Ehrsson Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma Cancer Treat Rep 68 1984 867 872
-
(1984)
Cancer Treat Rep
, vol.68
, pp. 867-872
-
-
Hafström, L.1
Hugander, A.2
Jönsson, P.E.3
Westling, H.4
Ehrsson, H.5
-
20
-
-
0031052291
-
Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation
-
F. Pinguet P. Martel M. Fabbro I. Petit P. Canal S. Culine Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation Anticancer Res 17 1997 605 612
-
(1997)
Anticancer Res
, vol.17
, pp. 605-612
-
-
Pinguet, F.1
Martel, P.2
Fabbro, M.3
Petit, I.4
Canal, P.5
Culine, S.6
-
23
-
-
85120104715
-
Phase I/II trial of high-dose melphalan (L-PAM) by isolated hepatic perfusion (IHP) in treatment of colorectal cancer confined to the liver [abstract]
-
A.E.M. Tollenaar A.L. Vahrmeijer H.J. Keizer J.H. Beijnen J.H. Van Dierendonck P.J.K. Kuppen Phase I/II trial of high-dose melphalan (L-PAM) by isolated hepatic perfusion (IHP) in treatment of colorectal cancer confined to the liver [abstract] Reg Cancer Treat 10 Suppl 1 1997 5 9
-
(1997)
Reg Cancer Treat
, vol.10 Suppl 1
, pp. 5-9
-
-
Tollenaar, A.E.M.1
Vahrmeijer, A.L.2
Keizer, H.J.3
Beijnen, J.H.4
Van Dierendonck, J.H.5
Kuppen, P.J.K.6
|